Quantinno Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Quantinno Capital Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.47M	Buy	8,312 +1,622	+24%	+$525K	﹤0.01%	1496
2025 Q4	$2.03M	Buy	6,690 +1,102	+20%	+$361K	﹤0.01%	1358
2025 Q3	$1.9M	Buy	5,588 +1,877	+51%	+$570K	0.01%	1248
2025 Q2	$898K	Buy	3,711 +1,143	+45%	+$280K	﹤0.01%	1351
2025 Q1	$699K	Buy	2,568 +1,221	+91%	+$285K	﹤0.01%	1270
2024 Q4	$249K	Buy	1,347 +33	+3%	+$6.74K	﹤0.01%	1457
2024 Q3	$295K	Buy	+1,314	New	+$236K	﹤0.01%	1271
2023 Q1	–	Sell	-998	Closed	-$220K	–	902
2022 Q4	$220K	Buy	+998	New	+$183K	0.02%	759

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Quantinno Capital Management's ONC Position: Q1 2026 in Review

Quantinno Capital Management increased its BeOne Medicines Ltd (ONC) stake by 24% in Q1 2026, buying an estimated $525K and bringing the position to 8,312 shares worth $2.47M. The position accounts for ﹤0.01% of the portfolio, ranked #1496.

Quantinno Capital Management first reported a position in ONC in Q4 2022 and has held it in 8 quarters since. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

Quantinno Capital Management held 8,312 shares of BeOne Medicines Ltd worth $2.47M as of Q1 2026.
Quantinno Capital Management bought 1,622 BeOne Medicines Ltd shares in Q1 2026, an estimated $525K.
BeOne Medicines Ltd made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #1496 holding.
Quantinno Capital Management first reported a position in BeOne Medicines Ltd in Q4 2022 and has held it in 8 quarters since.
281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.